HEALTHCBS NEWS
FDA launches safety study for abortion pill mifepristone, source says
The FDA has initiated a safety study of the abortion pill mifepristone, as confirmed by a senior FDA official to CBS News. This move could lead to the Trump administration imposing restrictions on the medication's access.
Related Signal
Adjacent reporting
- Hawley urges DOJ probe into abortion pill maker over safety concerns
- Eyes are on the Supreme Court for another abortion pill ruling
- Supreme Court temporarily extends women’s access to a widely used abortion pill
- Former FDA leaders, pharma speak out on mifepristone
- Supreme Court preserves broad access to abortion drug mifepristone
- Telehealth Abortion Is Still Possible Without Mifepristone